Mirador Therapeutics Appoints Gregg Gilbert as CFO to Drive Growth

Share This Post

Key Highlights

  • Mirador Therapeutics names Gregg Gilbert as new CFO
  • Gregg brings over 25 years of biopharma equity research and investment banking experience
  • Previously served as Managing Director at Bank of America Securities
  • Focused on advancing Mirador’s precision therapies for immunology and inflammation
  • Mirador raised over $400 million since its launch in 2024

Source: Business Wire

Notable Quotes

  • “We are thrilled to welcome Gregg at this critical point in our company’s trajectory. Gregg’s impressive Wall Street experience bridges corporate and investor perspectives, and will be invaluable to guiding our next phase of growth.”  Mark C. McKenna, Chairman and CEO at Mirador Therapeutics
  • “I am humbled to join this exceptionally talented and collaborative team as CFO, and look forward to making a meaningful impact as we work to deliver the next wave of precision medicines in I&I.” — Gregg Gilbert, CFO at Mirador Therapeutics

SoHC's Take

The appointment of Gregg Gilbert as CFO at Mirador Therapeutics signifies a strategic move to enhance its financial operations and investor relations as the company accelerates the development of next-generation precision therapies for immunology and inflammation. With over 25 years of experience advising biopharma companies and guiding capital strategies, Gregg’s leadership will be pivotal as Mirador transitions into its next growth phase. This appointment aligns with Mirador’s broader goal of rapidly building a diversified portfolio of transformational therapies.

Heading

Key Highlights Novo Nordisk partners with Hims & Hers, LifeMD, and Rofor streamlined Wegovy® access through telehealth.Wegovy® now available at ...
/
Key Highlights Ro now offers all Wegovy® doses for $499/month via NovoCare® PharmacyDirect access to FDA-approved GLP-1 medication through the ...
/
Episode Details: Join us on the latest episode, hosted by Jared S. Taylor! Our Guest: Dr. Jim Bonnette, Chief Medical ...
/
Key Highlights 28% reductionin documentation time for care teams20% increasein patient engagement through automated outreachAI Agentsmanage SMS/voice outreach, scheduling, and ...
/
Key Highlights Warner Roberts appointed as Calibrate’s Chief Commercial OfficerWill lead commercial strategy to scale workplace obesity solutionsCalibrate members report ...
/
Key Highlights Fully integratedwith Castlight’s healthcare benefits app 24/7 on-demand carevia chat, video, and voice High-quality carefor common conditions delivered ...
/

More To Explore

Total
0
Share